Cardiovascular disease in patients with coeliac disease: A systematic review and meta-analysis

Louise Emilsson1, Benjamin Lebwohl2, Johan Sundström3

  • 1Primary Care Research Unit, Vårdcentralen Värmlands Nysäter, Värmland County, Sweden; Department of Health Management and Health Economy, Institute of Health and Society, University of Oslo, Oslo, Norway.

Insights

Coeliac disease (celiac disease) is linked to a slightly higher risk of cardiovascular disease, particularly stroke. However, the evidence is limited, and more research is needed to confirm these findings.

Area of Science:

  • Gastroenterology and Cardiology
  • Epidemiology
  • Systematic Review and Meta-Analysis

Background:

  • Conflicting evidence exists regarding the association between celiac disease and cardiovascular disease (CVD) risk.
  • Previous studies have yielded inconsistent results, necessitating a comprehensive review.

Purpose of the Study:

  • To systematically review and meta-analyze the risk of cardiovascular disease in patients with celiac disease.
  • To consolidate existing evidence and provide a clearer understanding of the CVD risk associated with celiac disease.

Main Methods:

  • A systematic search of major databases (PubMed, Cinahl, EMBASE, Medline) was conducted up to January 5, 2015.
  • Ten English-language studies with over 20 patients were included and assessed for bias using the GRADE tool.
  • Random-effects models were employed to analyze the data, with heterogeneity assessed using the I(2) statistic.

Main Results:

  • The meta-analysis revealed an increased risk of stroke (OR 1.11; 95%CI 1.02-1.20) in celiac disease patients.
  • While risks for myocardial infarction and cardiovascular death were not significantly elevated, they were estimated with less certainty.
  • Moderate heterogeneity was observed for myocardial infarction risk, while other outcomes showed low heterogeneity.

Conclusions:

  • Celiac disease is associated with a modestly increased risk of cardiovascular disease, particularly stroke.
  • The current evidence base is limited, underscoring the need for further investigation to confirm these associations and elucidate underlying mechanisms.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.8K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
657
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
700